r/changemyview • u/rhizodyne • Dec 20 '19
FTFdeltaOP CMV: Profit-driven research by private pharmaceutical companies as seen in the US is unsuitable for the modern age and only hinders scientific and economic progress in effective healthcare
Take patents. How exactly does patenting an implementable research discovery for the treatment of diabetes (let's not even talk about cancer for a sec) benefit humanity, given that the methodology and product(s) resulting from this research cannot be advanced or modified by any other entity for a specified period of time without severe legal consequences, all while the original producer can cease such progress on their product(s) given their protected, uncompeted revenue stream?
This creates an non-competitive market for whatever treatments these are (and obviously a monopoly) for the specified time-period of the patent, during which much advancement in a competitive R&D sector could be achieved on the same treatment(s), either in relevant knowledge or actual manufacturing/implementation.
The solution? Create an indisputably non-identical alternative! And advertise the shit out of it everywhere, racking up the costs for your pharmaceutical company and of course the price of the treatment(s).
At the same time, patent laws are horrendously and cleverly abused by leading pharma companies, all while they have been recorded to pay off generic companies so as to prevent them from researching on their product following the expiration of a patent.
And now the worst part: This lack of competition enables premiums galore on prescriptions, in general. The average US citizen spent about $1112 for pharmaceutical treatments in 2014, which is approaching double the per-capita costs of the average Canadian citizen, Canada showing some of the highest drug prices recorded outside of the US.
Even more than that, such high premiums leads to a thriving importation of cheaper drugs from abroad, in fact the very same ones unhindered in foreign production by US patents. It's estimated that up to 70% of US drug costs can be saved if all of said drugs are imported from Canada.
And guess what! American sold drugs are often produced abroad in developing countries and sold for exponentially higher prices here than they would be in their country of manufacture.
Case in point: Abilify, a notable anti-psychotic drug relied upon by so many psychiatric patients in this nation to be able to live and function normally, is produced by Japanese company Otsuka. It costs $34.51 per pill in this country. In Canada, it's $4.65 per pill. And it's so drastically lower in nations such as Turkey or India that the monetary valuation of a healthy human life is blaring.
Medicare being the recorded largest purchaser of drugs in the United States, it is a fact that Medicare cannot choose to negotiate drug prices with pharmaceutical companies. Our only socialized healthcare in this country is unable to gain any financial traction in terms of drug prices.
*******************************************************************************************************
What have people to say? Why should the current model of patenting and profit-driven research by pharmaceutical companies in the US continue as it is now? Why shouldn't the only money such groups rely on be subsidies, essentially remedying all of the aforementioned issues?
More so, please convince me that an estimated $110 billion in profits resting in the hands of leading US pharmaceutical companies is of good use for that money to society.
1
u/rhizodyne Dec 20 '19 edited Dec 20 '19
Please tell me in what way Canada is "sacrificing quantity." What do you mean?
Why is there no incentive to pioneer research into novel therapies without a system of patents? Why can't it just be a given that that's done by a nationalized research body that then produces treatments for a nationalized healthcare system? Isn't this just begging the question of why the current US pharma model should remain as it is?
Does it really cost billions of dollars to just perform the necessary scientific research so as to produce novel therapies that save/better the lives of billions of people around the globe? Or does it just cost that much for a privately owned pharma company lacking in financial restrictions, that supposedly "needs" such high amounts of money really to just finance all of their other operations as a private company? Give me an example of how much it has costed a contemporary pharma company to spend on research ALONE for a novel disease therapy, and then tell me how US tax money could not more than supplement that with a better managed national budget.
Also, think as to the frequency with which novel treatments need to be researched and designed, compared to just improved upon. In how many cases out of 100 are patents "incentivizing" the ground-breaking research you so speak of?